A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely ...

Dupilumab treatment of atopic dermatitis resulted in long-term skin improvements linked to changes in skin’s the molecular composition.

In this video, Peter Lio, MD, discussed updates on topical agents, biologics and drugs in the pipeline in atopic dermatitis from presentations at the American Academy of Dermatology meeting.

Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...

Medically reviewed by Casey Gallagher, MD Atopic dermatitis (the most common type of eczema) causes dry, itchy skin with ...

Netherlands: A recent real-world, long-term study from the BioDay Registry has highlighted a significant incidence of ...

A cohort study finds children with early-onset atopic dermatitis to be at increased risk for uveitis, highlighting a need for ophthalmologic monitoring in youth.

Underlying social and economic barriers in the U.S. may play a significant role in the higher rates of atopic dermatitis.

Researchers examined the risk for serious infection among patients with atopic dermatitis treated with Janus kinase inhibitors vs Th2 cytokine inhibitors.

Atopic dermatitis is an inflammatory skin condition ... crisaborole (a topical ointment), and dupilumab (a biologic) than white patients. It’s not clear what factors play the biggest role ...